<DOC>
	<DOCNO>NCT03006406</DOCNO>
	<brief_summary>Gonadotropin-releasing hormone analogue ( GnRH-a ) synthetic decapeptide compound down-regulate pituitary function cause temporary low estrogen state . Since endometriosis estrogen-dependent disease , use long-acting GnRH-a control growth endometriosis inhibit ovary function.Some scholar find , adenomyosis patient receive super long protocol ( pretreatment long-acting GnRH-a 1-2 month ) IVF treatment , pregnancy outcome comparable control normal uterus . Thus , aim study compare clinical pregnancy rate patient treat GnRH-a 1 , 2 month .</brief_summary>
	<brief_title>Effect Shorten Gonadotropin-releasing Hormone Agonist Therapy Outcome Vitro Fertilization-Embryo Transfer Patients With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>first IVF cycle ; normal ovarian reserve ( FSH ( 10miu/mlï¼› antral follicle count ) 3 ) normal uterine Preimplantation genetic diagnosis cycle ; Oocyte donation cycle</criteria>
	<gender>Female</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>42 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>endometriosis</keyword>
	<keyword>long term GnRH-a</keyword>
</DOC>